JPMORGAN CHASE & CO - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 32 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$501
-34.3%
6680.0%0.00%
Q2 2023$762
-23.8%
6680.0%0.00%
Q1 2023$1,000
+99900.0%
6680.0%0.00%
Q4 2022$1
-100.0%
668
-61.0%
0.00%
Q3 2022$3,0000.0%1,713
+31.7%
0.00%
Q2 2022$3,000
-99.2%
1,301
-99.2%
0.00%
Q1 2022$361,000
-61.0%
156,365
-2.1%
0.00%
Q4 2021$926,000
-48.0%
159,778
-5.6%
0.00%
Q3 2021$1,781,000
+1.9%
169,340
-5.4%
0.00%
Q2 2021$1,748,000
-22.7%
179,078
+15.1%
0.00%
Q1 2021$2,262,000155,6470.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$231,0000.01%
FNY Investment Advisers, LLC 3,500$8,0000.01%
LEO BROKERAGE, LLC 14,845$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$88,0000.00%
UBS Group AG 13,618$31,0000.00%
RHUMBLINE ADVISERS 16,169$37,0000.00%
Ellevest, Inc. 19$00.00%
TWO SIGMA INVESTMENTS, LP 62,184$144,0000.00%
FMR LLC 179$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,375$24,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders